A) Schematic summary of currently known alterations in dopaminergic neuronal activity and dopamine release after ketamine exposure.16,17
B) Schematic summary (this study) of the brain-wide alterations in the DA system after 10 days of repeated ketamine (30 and 100 mg/kg) exposure. Up and down arrows indicate increase and decrease, respectively. Note that, for the 30 mg/kg ketamine treatment, statistically significant decreases in TH+ neuron counts were only observed in DR, DMH, and MPN and increase in ZI and SNr. The TH+ neuronal projections changes are only shown for the 100 mg/kg (10 days) treatment. Abbreviations used are standard Allen Brain Atlas terms, as follows: ACA, anterior cingulate area; ACB, nucleus accumbens; ARH, arcuate hypothalamic nucleus; AUD, auditory areas; BST, bed nuclei of the stria terminalis; CLI, central linear nucleus raphe; CP, caudoputamen; DMH, dorsomedial nucleus of the hypothalamus; DR, dorsal nucleus raphe; ENT, entorhinal area; FRP, frontal pole, cerebral cortex; HPF, hippocampal formation; IF, interfascicular nucleus raphe; ILA, infralimbic area; LA, lateral amygdalar nucleus; LP, lateral posterior nucleus of the thalamus; MPN, medial preoptic nucleus; MRN, midbrain reticular nucleus; ORB, orbital area; PAG, periaqueductal gray; PIR, piriform area; PL, prelimbic area; PPN, pedunculopontine nucleus; PVH, paraventricular hypothalamic nucleus; PVp, paraventricular hypothalamic nucleus, posterior part; RR, midbrain reticular nucleus, retrorubral area; SAG, nucleus sagulum; SF, septofimbrial nucleus; SNc, substantia nigra, compact part; SPA, subparafascicular area; SPF, subparafascicular nucleus; TM, tuberomammillary nucleus; TRS, triangular nucleus of septum; TT, taenia tecta; TU, tuberal nucleus; VIS, visual areas; VMH, ventromedial hypothalamic nucleus; VTA, ventral tegmental area; ZI, zona incerta.